Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -13.19% vs 18.74% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -49.36% vs 37.40% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -54.99% vs 28.16% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -93.58% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -13.19% vs 18.74% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.72% vs 12.72% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -49.36% vs 37.40% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 9.88% vs 2.38% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -54.99% vs 28.16% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -10.05% vs 3.67% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -93.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






